Welcome to LookChem.com Sign In|Join Free

CAS

  • or

20816-79-9

Post Buying Request

20816-79-9 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

20816-79-9 Usage

Uses

1-Bromo-8-chloronaphthalene is a useful reagent in the preparation of peri-substituted naphthalene series.

Check Digit Verification of cas no

The CAS Registry Mumber 20816-79-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,0,8,1 and 6 respectively; the second part has 2 digits, 7 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 20816-79:
(7*2)+(6*0)+(5*8)+(4*1)+(3*6)+(2*7)+(1*9)=99
99 % 10 = 9
So 20816-79-9 is a valid CAS Registry Number.

20816-79-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 13, 2017

Revision Date: Aug 13, 2017

1.Identification

1.1 GHS Product identifier

Product name 1-bromo-8-chloronaphthalene

1.2 Other means of identification

Product number -
Other names 1-bromo-8-chloro-naphthalene

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:20816-79-9 SDS

20816-79-9Downstream Products

20816-79-9Relevant articles and documents

-

Bergmann,Hirshberg

, p. 331,334 (1936)

-

COVALENT RAS INHIBITORS AND USES THEREOF

-

, (2021/06/04)

The disclosure features compounds, or pharmaceutically acceptable salts thereof, alone and in combination with other therapeutic agents, pharmaceutical compositions, and protein conjugates thereof, capable of modulating biological processes including Ras, and their uses in the treatment of cancers.

KRAS G12C INHIBITORS

-

, (2020/07/25)

The present invention relates to compounds that inhibit KRas G12C. In particular, the present invention relates to compounds that irreversibly inhibit the activity of KRas G12C, pharmaceutical compositions comprising the compounds and methods of use therefor.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 20816-79-9